Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)

Technology Stocks News 14

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) Director Gary E. Frashier unloaded 55,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $8.00, for a total transaction of $440,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -3.07% in last session and finished the day at $7.58. Traded volume was 13.15million shares in the last session and the average volume of the stock remained 4.69million shares. The beta of the stock remained 1.89. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) insider ownership is 13.04%.

MannKind Corporation (NASDAQ:MNKD) VP Diane Palumbo unloaded 17,902 shares of the company’s stock on the open market in a transaction dated Monday, June 16th. The stock was sold at an average price of $10.59, for a total transaction of $189,582.18. Following the completion of the transaction, the vice president now directly owns 140,956 shares in the company, valued at approximately $1,492,724. MannKind Corporation (NASDAQ:MNKD) dropped -0.47 percent to $10.60 Tuesday on volume of 6.58million shares. The intra-day range of the stock was $10.51 to $10.75. MannKind Corporation (NASDAQ:MNKD) has a market capitalization of $4.12billion.

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) CEO Don M. Bailey sold 40,000 shares of Questcor Pharmaceuticals stock on the open market in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $89.83, for a total value of $3,593,200.00. Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s stock on June 17, 2014 reported a increase of 2.86% to the closing price of $91.11. Its fifty two weeks range is $42.01 -$94.20. The total market capitalization recorded $5.56billion. The overall volume in the last trading session was 1.40million shares. In its share capital, QCOR has 60.98million outstanding shares.

Dyax Corp. (NASDAQ:DYAX) CFO George V. Migausky unloaded 16,000 shares of Dyax Corp. stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $8.26, for a total transaction of $132,160.00. Following the transaction, the chief financial officer now directly owns 85,350 shares of the company’s stock, valued at approximately $704,991. On Tuesday, shares of Dyax Corp. (NASDAQ:DYAX) advanced 2.38% to close the day at $8.81. Company return on investment (ROI) is -15.80% and its monthly performance is recorded as 42.02%.  Dyax Corp. (NASDAQ:DYAX) quarterly revenue growth is -4.91%.

Illumina, Inc (NASDAQ:ILMN) CFO Marc Stapley sold 1,422 shares of the stock on the open market in a transaction dated Monday, June 16th. The shares were sold at an average price of $169.25, for a total value of $240,673.50. Following the sale, the chief financial officer now directly owns 21,996 shares in the company, valued at approximately $3,722,823. Illumina, Inc. (NASDAQ:ILMN) stock performance was 0.28% in last session and finished the day at $169.85. Traded volume was 783,171.00million shares in the last session and the average volume of the stock remained 2.07million shares. The beta of the stock remained 0.54. Illumina, Inc. (NASDAQ:ILMN) insider ownership is 1.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone